|
|
||||||||
Division of Physiology, Department of Medicine, University of California, San Diego, La Jolla, California 92093
| |
ABSTRACT |
|---|
|
|
|---|
There is
evidence that the concentration of the high-energy phosphate
metabolites may be altered during steady-state submaximal exercise
by the breathing of different fractions of inspired
O2 (FIO2). Whereas
it has been suggested that these changes may be the result of
differences in time taken to achieve steady-state O2 uptake
(
O2) at different
FIO2 values, we postulated that they are due to a direct effect of
O2 tension. We used
31P-magnetic resonance
spectroscopy during constant-load, steady-state submaximal exercise to
determine 1) whether changes in
high-energy phosphates do occur at the same
O2 with varied
FIO2 and
2) that these changes are not due to
differences in
O2
onset kinetics. Six male subjects performed steady-state submaximal plantar flexion exercise [7.2 ± 0.6 (SE) W] for 10 min
while lying supine in a 1.5-T clinical scanner. Magnetic resonance
spectroscopy data were collected continuously for 2 min before
exercise, 10 min during exercise, and 6 min during recovery. Subjects
performed three different exercise bouts at constant load with the
FIO2 switched after 5 min of
the 10-min exercise bout. The three exercise treatments were
1)
FIO2 of 0.1 switched to
0.21, 2)
FIO2 of 0.1 switched to
1.00, and 3)
FIO2 of 1.00 switched to
0.1. For all three treatments, the
FIO2 switch significantly (P
0.05) altered phosphocreatine:
1) 55.5 ± 4.8 to 67.8 ± 4.9% (%rest); 2) 59.0 ± 4.3 to
72.3 ± 5.1%; and 3) 72.6 ± 3.1 to 64.2 ± 3.4%, respectively. There were no significant
differences in intracellular pH for the three treatments. The results
demonstrate that the differences in phosphocreatine concentration with
varied FIO2 are not the
result of different
O2
onset kinetics, as this was eliminated by the experimental design.
These data also demonstrate that changes in intracellular oxygenation,
at the same work intensity, result in significant changes in cell homeostasis and thereby suggest a role for metabolic control by O2 even during submaximal
exercise.
fraction of inspired oxygen; skeletal muscle; intracellular oxygenation
| |
INTRODUCTION |
|---|
|
|
|---|
THERE IS SOME EVIDENCE that, at similar submaximal work
rates, blood and intracellular lactate, intracellular phosphocreatine (PCr), and other proposed regulators of respiration
(Pi and ADP) may vary
significantly with different fractions of inspired
O2 (FIO2) (13, 18, 21).
However, at submaximal work rates, levels of
O2 uptake
(
O2) remained constant while
breathing varied FIO2 (13,
15, 18, 21-23, 30, 31); hence, the causes of these changes in
metabolic processes that occur during steady-state submaximal exercise
while breathing varied FIO2
have not been fully elucidated. It has been suggested that these
changes at the same
O2 may be
a result of differences in
O2
onset kinetics that occur when
FIO2 is varied (16, 17, 23).
Additionally, it has recently been proposed that the time required to
achieve a steady-state
O2 may
set the subsequent levels of cytosolic signals driving mitochondrial recruitment (11), and the time course for
O2 onset has been related to
changing PCr concentrations in muscle at the start of exercise (1,
26-28). With respect to
FIO2, exercise in hyperoxia
has been shown to have short
O2 onset times (23, 24),
which may result in small depletions of PCr, compared with exercise in
hypoxic situations in which the onset time is longer, and may result in
greater PCr hydrolysis and an increased reliance on anaerobic ATP
turnover during the extended transition to steady state (17, 23).
However, even under steady-state conditions, there is evidence that
metabolic processes can be affected by alterations in tissue or
intracellular oxygenation (4, 12, 37). It has been shown that
variations in intracellular PO2 can
alter the ratio of the concentration of ATP to the concentration of ADP
([ATP]/[ADP]) at a given steady-state
O2 to maintain that rate of
cellular respiration (35-37). Any alterations in the concentration of O2
([O2]) will change the
concentrations of the other reactants of oxidative phosphorylation to
maintain kinetic steady state. Thus changes seen in metabolites at a
similar
O2 when
FIO2 is varied may be the
result of changes in intracellular oxygenation and not of differences
in
O2 onset kinetics.
However, there is little direct experimental evidence that alterations
in tissue oxygenation during steady-state exercise can influence
intracellular metabolic processes.
The purpose of this study was to test in vivo the hypotheses that
1) changes in intracellular
metabolic processes do occur at constant submaximal
O2 as
FIO2 is changed and
2) these changes are not due to
differences in
O2 onset
kinetics. Human subjects performed submaximal steady-state plantar
flexion exercise, during which
FIO2 was varied (0.1, 0.21, and 1.00) and the levels of PCr were measured by
31P-magnetic resonance
spectroscopy (MRS). The results demonstrate that there were significant
changes in the intracellular metabolic processes due to altered
FIO2 and that these changes were, by experimental design, not the result of
O2 onset kinetics but were
likely the result of changes in intracellular oxygenation.
| |
METHODS |
|---|
|
|
|---|
Subjects. Six healthy men, aged 21-42 yr [32 ± 6.8 (SD) yr], volunteered for this study and gave written informed consent. The study was approved by the Human Subjects Committee of the University of California, San Diego. Subjects were all healthy and active, ranging from recreational to well-trained athletes. The subjects refrained from strenuous exercise for 24 h before data collection.
Exercise protocol. Subjects were familiarized with plantar flexion exercise in the confines of a whole body magnetic resonance imaging system. At this time, ~60% of maximum work rate was determined for each subject. Subjects performed constant-load submaximal plantar flexion at this intensity (7.2 ± 0.6 W) at a frequency of 1 contraction/s (keeping time with an electronic metronome) while lying supine in a superconducting 1.5-T magnet. The exercise was a square-wave protocol with the same work rate maintained for each FIO2. Throughout each exercise bout, subjects breathed through a low-resistance, two-way breathing valve (2700, Hans-Rudolph, Kansas City, MO), and end-tidal O2 and CO2 were sampled continuously, allowing arterial O2 saturation to be calculated (assuming no alveolar-to-arterial PO2 gradient and no significant metabolic acidosis). Heart rate was monitored continuously with a finger probe (Omni-Trak, In Vivo Research) throughout the experiment. After a 5-min warm-up period followed by 5 min of rest, each subject performed a control bout of 10 min of exercise under normoxic conditions. After 40 min of rest, subjects performed three separate exercise bouts with the FIO2 switched after 5 min of the 10-min exercise. MRS data were acquired continuously for 2 min before exercise, 10 min during exercise, and 6 min during recovery. The subjects breathed the first FIO2 for 4 min before the commencement of MRS acquisition, then for 2 min before exercise with MRS data acquisition, and then for the first 5 min of constant-load, constant-rate exercise (11 min total). After this initial 5 min of exercise, the FIO2 was switched, and the subjects continued to exercise while breathing the second FIO2 (without change in work rate) for a further 5 min and for the 6 min of recovery (11 min total). The three FIO2 switches were 1) 0.1 switched to 0.21 (hypoxia to normoxia; Hypo-Norm), 2) 0.1 switched to 1.00 (hypoxia to hyperoxia; Hypo-Hyper), and 3) 1.00 switched to 0.1 (hyperoxia to hypoxia; Hyper-Hypo). Subjects were allowed 40 min to rest between exercise bouts. The order of the three treatments was varied to allow all six possible orders to be performed once. The subjects were unaware of the treatment order during the exercise.
31P-MRS. MRS was performed by using a clinical 1.5-T General Electric Signa system (version 4.8) operating at 25.86 MHz for 31P. 31P-MRS data were acquired with a transmit/receive surface coil (diameters 20 and 10 cm, respectively) placed under the calf at its maximum diameter. The centering of the leg over the coil was confirmed by T1-weighted 1H localizing images obtained in the axial plane. Magnetic field homogeneity was optimized by shimming on the proton signal from tissue water. For 31P-MRS, the pulse power was adjusted so that ~72% of the signal acquired was from tissue within 5 cm of the surface coil. The spectral width was 2,500 Hz, and data were acquired continuously for 18 min with a single free induction decay (FID) generated every 4 s. Thus 270 single FIDs were acquired during the 2-min rest period, 10-min exercise period, and 6-min recovery period. As a result, the data can be expressed with a time resolution of 4 s or summed as spectra representing an average over a defined time period.
Data analysis.
Data were processed by using SAGE/IDL software on a Silicon Graphics
Indigo workstation. Each FID consisted of 1,024 complex points and was
processed with 5-Hz exponential line broadening before zero filling and
Fourier transformation. Summing 10 spectra provided a sufficient
signal-to-noise ratio to allow the determination of PCr levels at 40-s
time intervals during the experiment. All spectra were manually phased
by using zero and first-order phase corrections. The levels of PCr
determined from the intensity of that peak were normalized to 100% by
using as a reference the average value obtained for the last 40 s of
rest for each subject. Muscle intracellular pH was calculated from the
chemical shift difference (
) of the
Pi peak relative to the PCr peak
by using the following equation: pH = 6.75 + log[(
3.27)/(5.69
)] (34). PCr and pH
values were pooled and expressed as the means ± SE for the six
subjects and plotted as a function of time. The changing PCr levels and
pH values in response to varied
FIO2 were statistically
assessed by a one-way repeated-measures ANOVA. A 0.05 level of
significance was used.
| |
RESULTS |
|---|
|
|
|---|
The levels of PCr and pH determined with a temporal resolution of 40 s for the rest, exercise, and recovery periods are shown in Figs. 1 and 2, respectively. On commencement of exercise, there is a rapid net hydrolysis of PCr, reaching a steady-state level of 65.7 ± 4.3% of resting levels under control (normoxic) conditions (Fig. 1A). The following values of PCr reported for the three different FIO2 switch treatments represent the average of the last 40 s of data acquired before the FIO2 switch and before the recovery period and are expressed as a percentage of resting PCr levels. For Hypo-Norm, PCr levels fell to 55.5 ± 4.8% and after the switch increased to 67.8 ± 4.9% (Fig. 1B). For Hypo-Hyper, PCr levels fell to 59.0 ± 4.3% and increased to 72.3 ± 5.1% after the switch (Fig. 1C). For Hyper-Hypo, PCr levels fell to 72.6 ± 3.1% and decreased further to 64.2 ± 3.4% after the switch (Fig. 1D). For all three treatments, the changes in PCr levels after the FIO2 switch were significantly different (P < 0.05), compared with the first FIO2 breathed, even though the work rate remained constant.
|
|
The intracellular pH data in Fig. 2 show that, for the control exercise bout and the three FIO2 switch bouts, there is an increase in pH of ~0.1 at the commencement of exercise. There were no significant differences in pH values for the 40 s before the FIO2 switch and before the recovery period for any of the treatments, i.e., at the same times that PCr levels were determined. The PCr and pH data, as well as arterial O2 saturation and heart rate for the 40 s before the switch and before the recovery period, are summarized in Table 1.
|
The plots for Hypo-Hyper and Hyper-Hypo are overlaid in Fig. 3. This shows that the PCr levels were better maintained when the FIO2 of 0.1 was second compared with when it was first (64.2 ± 3.4% vs. 59 ± 4.3%). When the second FIO2 was 1.00, PCr levels increased and matched the levels maintained when 1.00 was the first FIO2 (72.3 ± 5.1% vs. 72.6 ± 3.1%). In Fig. 3, the numbers in parentheses are the arterial O2 saturations for the 40 s before the FIO2 switch and before the recovery period. The arterial O2 saturation was 70.5 ± 2.9% with the initial 0.1 FIO2 in Hypo-Hyper, but it was higher, at 77.0 ± 0.5%, when 0.1 FIO2 was second in Hyper-Hypo. It is interesting to note that the higher saturation when hypoxia was the second treatment did not appear to be a function of time after the FIO2 switch, as exercising for longer periods while breathing the FIO2 of 0.1 as the second treatment did not cause a further fall in saturation.
|
| |
DISCUSSION |
|---|
|
|
|---|
The major findings of this study were that 1) changes in FIO2 resulted in altered levels of PCr with exercise at the same constant submaximal intensity and 2) this effect was clearly not the result of onset kinetics.
O2 onset kinetics.
Numerous studies have documented that, at submaximal work intensity,
O2 is independent of the
FIO2 breathed (13, 15, 18,
21-23, 30, 31). The altered cellular energy states at varied
FIO2 observed in this study
occurred at the same submaximal work intensity and, therefore, by
assumption, the same
O2.
Previous investigators (16, 23) have suggested that any metabolic
changes with altered FIO2
may be the result of differences in
O2 onset kinetics, i.e., the
time required for the muscle to achieve a steady state of respiration.
It has been demonstrated that breathing low
FIO2 results in slower onset
times to steady state and that faster kinetics occur with the breathing
of higher than normal FIO2
(23, 24). In addition, it was recently proposed that the time required to achieve a steady-state
O2
may influence the metabolic state of the cell by setting the subsequent
levels of the cytosolic signals driving mitochondrial recruitment (11).
A longer time to reach steady state with reduced
FIO2 would result in a
higher level of substrate-level phosphorylation, resulting in increased
lactate production and greater PCr hydrolysis. The reverse would be
true with the breathing of a hyperoxic gas mixture. This study tested
the hypothesis that any changes in intracellular metabolic processes
are due to some direct effect of breathing-varied FIO2 and not to alterations
in the time taken to achieve a new steady-state
O2 after the onset of
exercise. The experimental design was such that by "quick
switching" the FIO2 after 5 min of steady-state exercise, the effect of
FIO2 could be studied
independent of onset kinetics. Thus, because PCr hydrolysis was
significantly different after the
FIO2 switch, these data
clearly show that onset kinetics do not explain the altered levels of
PCr with varied FIO2.
FIO2 and muscle
PCr.
The data presented in Fig. 1 and summarized in Table 1 show the
different levels of PCr reached while the same work rate is maintained
in response to altered FIO2.
In Fig. 3, the overlaid plots of Hypo-Hyper and Hyper-Hypo showing the
switches between hypoxia and hyperoxia suggest that PCr levels during
steady-state exercise may have been influenced by arterial
O2 saturation. When the
FIO2 of 0.1 was second in
treatment order, the saturation did not fall to the same extent as
it did when the FIO2 of
0.1 was first, thereby resulting in different levels of PCr at the
same FIO2 (Table 1, Fig. 3).
By the end of the exercise period in Hyper-Hypo, the PCr levels
appeared to have reached a new steady-state level, reflecting the
higher arterial O2 saturation of
77%. The PCr levels were the same in hyperoxia regardless of whether
the FIO2 of 1.00 was first
or second in treatment order. Hyperoxic conditions, such as those
encountered in this study (100%
O2), will fully saturate
arterial blood, which results in an increase of only ~3% over
normoxia but will give rise to arterial
PO2 values of ~650 Torr (an
almost 6-fold increase over normoxia). The effects of these
differences in arterial PO2, caused
by the varied FIO2, on
myocyte energetics during exercise are shown in Figs.
4 and 5.
When the data from Hypo-Norm are overlaid with the control data, it can
be seen that the PCr levels rise to similar levels as those obtained in
the control setting after the
FIO2 switch from hypoxia to normoxia (Fig. 4, Table 1). In comparison, when the data from Hypo-Hyper are overlayed with the control data, the PCr levels begin
below and tend to rise above the control levels after the FIO2 switch from hypoxia to
hyperoxia (Fig. 5, Table 1). Additionally, the PCr level when hyperoxia
was the first treatment fell to 72.6 ± 3.1% and was
significantly higher compared with the 65.7 ± 4.3% PCr level for
the control bout (P
0.01, Table 1).
In this situation, arterial O2
saturations, and thereby arterial
[O2], were similar,
but arterial PO2 was certainly higher. Accordingly, there was less PCr hydrolysis while the same rate
of ATP turnover was maintained. This suggests that the higher arterial
PO2 in hyperoxia, even at nearly the
same arterial saturation and
[O2], influenced the
PCr level required for the same submaximal work rate.
|
|
O2 tension and myocyte metabolism. At the end of the O2 cascade, the O2 required for oxidative phosphorylation diffuses from the capillary to the cytoplasm and finally to the mitochondria. This movement of O2 from the blood to the mitochondria depends on a PO2 difference between these two sites. The diffusion-induced pressure difference between the capillary and the cytoplasm is also dependent on the flux of O2, determined by the rate of mitochondrial respiration. Previous intravascular-to-intracellular investigations of PO2 have demonstrated that cellular PO2 rises and falls with an increase or decrease in calculated mean capillary PO2, which occurs when a hyperoxic or hypoxic gas mixture is breathed (31, 32). Richardson and colleagues (31), using proton MRS to detect myoglobin desaturation and hence estimate intracellular PO2, have reported muscle intracellular PO2 values of 3.1 and 2.1 Torr for subjects performing isolated quadriceps exercise while breathing normoxic and hypoxic (12% O2) gases, respectively. These results were confirmed and extended in a more recent study in which intracellular PO2 values of 2.6 ± 0.8, 3.2 ± 0.7, and 4.8 ± 2.0 Torr were measured for subjects exercising while breathing 12, 21, and 100% O2, respectively (32). An interesting observation in those studies was that intracellular PO2 was unaltered from submaximal to maximal exercise. Because exercise intensity has not been shown to affect intracellular PO2, we can directly relate those previous findings to the present study, as the subjects were exercising at ~60% of maximum. On the basis of this previous work, it is almost certain that changes in FIO2 and the subsequent changes in arterial PO2 altered intracellular PO2. We postulate that it was these alterations in intracellular PO2 that resulted in altered levels of PCr with exercising at a steady state. As the oxymyoglobin dissociation curve is extremely steep at low PO2, a small change in mean intracellular PO2 at these low PO2 values will cause large changes in myocyte [O2], as most of the myocyte O2 is myoglobin bound (38).
Our suggestion that alterations in tissue oxygenation influence PCr hydrolysis is consistent with the findings of Wilson and colleagues (9, 35, 37), who have demonstrated that regulatory parameters of oxidative phosphorylation adjust to maintain a constant rate of ATP synthesis over a wide range of O2 tensions. The respiratory rate may be maintained constant when O2 tension is varied by changing values of cytosolic [ATP]/[ADP][Pi] and intramitochondrial [NAD+]/[NADH]. Mitochondrial oxidative phosphorylation is dependent on [O2] over a broad physiological range and may even act as a tissue O2 sensor (35). Thus alterations in tissue oxygenation may cause changes in the regulatory signals required to drive mitochondrial respiration. The changing levels of PCr reported here imply a corresponding change in concentrations of other proposed regulators of oxidative phosphorylation such as ADP and Pi (3, 5). The dependence of [ADP] on PCr concentration has been used to relate metabolites observable by MRS to respiration rate in muscle (5, 6). In a series of studies using isolated in situ working dog gastrocnemius, Hogan et al. (12, 14) have shown that a larger change in any of the proposed regulators of tissue respiration (i.e., PCr, ADP, Pi, ATP/ADP · Pi) was required to achieve a given
O2 in response to a lower
vascular PO2 caused by hypoxic
conditions. Their results suggest that the sensitivity of mitochondrial
respiration to the proposed regulators of tissue respiration may be
altered by the level of tissue oxygenation, thereby demonstrating the
importance of O2 as a modulator of
the regulators of tissue respiration. Additionally, our results are consistent with theories of kinetic control of respiration by all four
substrates of oxidative phosphorylation as proposed by From et al. (10)
and Zimmer et al. (39) from studies of myocardial energetics. In these
proposals, there is no single substrate that is rate determining;
rather, the same level of
O2
can be achieved by different levels of the four substrates.
Modulation of respiratory regulation by O2. It has been demonstrated that PCr hydrolysis is important not only for substrate-level phosphorylation but also as a signal for mitochondrial respiration (7, 25, 29). The rate of ATP production in the mitochondria is tightly coupled to the utilization of ATP by the myofibrils in the cytoplasm. Thus the signal that couples ATP hydrolysis to its production must travel from the point of utilization to the mitochondria, where oxidative phosphorylation occurs. It has been suggested that, rather than ADP and Pi diffusing between the sites of utilization and production, PCr acts as a shuttle of high-energy phosphate (2, 19). Creatine kinase is present in the cytosol close to myosin ATPase and in the mitochondria (2, 19, 20, 33). At the ATPase in the cytosol, PCr serves as the phosphate donor restoring ADP to ATP, locally generating the ATP utilized in contraction. Creatine recycles back to the mitochondria and is phosphorylated back to PCr and thus may influence the control of oxidative phosphorylation. In this way, PCr is a specific carrier of high-energy phosphate, whereas creatine serves as the primary phosphate acceptor. PCr then would serve as a signal linking ATP utilization in the cytosol to production in the mitochondria. The data presented in the present study show PCr levels rising or falling with increased or decreased FIO2, suggesting that O2 is modulating one of the proposed regulators of tissue respiration during steady-state exercise, even when the global O2 availability is well above that considered critical for tissue respiration (8). Whereas at submaximal work rates these metabolic adjustments may have minimal impact on cell function, the differences in PCr hydrolysis resulting from the differences in cell oxygenation may profoundly influence cell function at higher work rates as both glycolysis and contractility are affected by [Pi].
This study demonstrated that alterations in skeletal muscle metabolic processes occur at constant work rates with varied FIO2 and that these responses were not the result of
O2 onset kinetics. In
addition, the results suggest that tissue or intracellular oxygenation
may play a role in the modulation of the regulators of cellular
respiration and thereby suggest that cellular levels of
O2 may influence metabolic control
even during submaximal exercise.
| |
ACKNOWLEDGEMENTS |
|---|
The authors thank Dr. Peter Wagner for many helpful discussions and Kuldeep Tagore for valuable technical assistance.
| |
FOOTNOTES |
|---|
This research was supported by National Heart, Lung, and Blood Institute Grant HL-17731. R. S. Richardson was a Parker B. Francis Fellow in Pulmonary Research during this study.
Address for reprint requests: L. J. Haseler, Dept. of Medicine 0623A, Univ. of California, San Diego, La Jolla, CA 92093-0623 (E-mail: lhaseler{at}ucsd.edu).
Received 29 December 1997; accepted in final form 2 June 1998.
| |
REFERENCES |
|---|
|
|
|---|
1.
Barstow, T. J.,
S. Buchthal,
S. Zanconato,
and
D. M. Cooper.
Muscle energetics and pulmonary oxygen uptake kinetics during moderate exercise.
J. Appl. Physiol.
77:
1742-1749,
1994
2.
Bessman, S. P.,
and
P. J. Geiger.
Transport of energy in muscle: the phosphorylcreatine shuttle.
Science
211:
448-452,
1981
3.
Binzoni, T.,
E. Hiltbrand,
T. Yano,
and
P. Cerretelli.
Step vs. progressive exercise: the kinetics of phosphocreatine hydrolysis in human muscle.
Acta Physiol. Scand.
159:
209-215,
1997[Medline].
4.
Bylund-Fellenius, A.,
P. M. Walker,
A. Elander,
S. Holm,
J. Holm,
and
T. Schersten.
Energy metabolism in relation to oxygen partial pressure in human skeletal muscle during exercise.
Biochem. J.
200:
247-255,
1981[Medline].
5.
Chance, B.,
J. S. Leigh,
J. Kent,
and
K. McCully.
Metabolic control principles and 31P NMR.
Federation Proc.
45:
2915-2920,
1986[Medline].
6.
Chance, B.,
J. S. Leigh,
J. Kent,
K. McCully,
S. Nioka,
B. J. Clark,
J. M. Maris,
and
T. Graham.
Multiple controls of oxidative metabolism in living tissues as studied by phosphorus magnetic resonance.
Proc. Natl. Acad. Sci. USA
83:
9458-9462,
1986
7.
Connett, R. J.
Analysis of metabolic control: new insights using scaled creatine kinase model.
Am. J. Physiol.
254 (Regulatory Integrative Comp. Physiol. 23):
R949-R959,
1988
8.
Connett, R. J.,
C. R. Honig,
T. E. J. Gayeski,
and
G. A. Brooks.
Defining hypoxia: a systems view of
O2, glycolysis, energetics, and intracellular PO2.
J. Appl. Physiol.
68:
833-842,
1990
9.
Erecinska, M.,
and
D. F. Wilson.
Regulation of cellular energy metabolism.
J. Membr. Biol.
70:
1-14,
1982[Medline].
10.
From, A. H. L.,
S. D. Zimmer,
S. P. Michurski,
P. Mohanakrishnan,
V. K. Ulstad,
W. J. Thoma,
and
K. Ugurbil.
Regulation of the oxidative phosphorylation rate in the intact cell.
Biochemistry
29:
3731-3743,
1990[Medline].
11.
Green, H. J.,
J. Cadefau,
R. Cusso,
M. Ball-Burnett,
and
G. Jamieson.
Metabolic adaptations to short-term training are expressed early in submaximal exercise.
Can. J. Physiol. Pharmacol.
73:
474-482,
1995[Medline].
12.
Hogan, M. C.,
P. G. Arthur,
D. E. Bebout,
P. W. Hochachka,
and
P. D. Wagner.
Role of O2 in regulating tissue respiration in dog muscle working in situ.
J. Appl. Physiol.
73:
728-736,
1992
13.
Hogan, M. C.,
R. H. Cox,
and
H. G. Welch.
Lactate accumulation during incremental exercise with varied inspired oxygen fractions.
J. Appl. Physiol.
55:
1134-1140,
1983
14.
Hogan, M. C.,
S. Nioka,
W. F. Brechue,
and
B. Chance.
A 31P-NMR study of tissue respiration in working dog muscle during reduced O2 delivery conditions.
J. Appl. Physiol.
73:
1662-1670,
1992
15.
Hogan, M. C.,
and
H. G. Welch.
Effect of altered arterial O2 tensions on muscle metabolism in dog skeletal muscle during fatiguing work.
Am. J. Physiol.
251 (Cell Physiol. 20):
C216-C222,
1986
16.
Hughes, R. L.,
M. Clode,
R. H. T. Edwards,
T. J. Goodwin,
and
N. L. Jones.
Effect of inspired O2 on cardiopulmonary and metabolic responses to exercise in man.
J. Appl. Physiol.
24:
336-347,
1968
17.
Hughson, R. L.,
J. K. Shoemaker,
M. E. Tschakovsky,
and
J. M. Kowalchuk.
Dependence of muscle
O2 on blood flow dynamics at onset of forearm exercise.
J. Appl. Physiol.
81:
1619-1626,
1996
18.
Idstrom, J. P.,
V. H. Subramanian,
B. Chance,
T. Schersten,
and
A. Bylund-Fellenius.
Oxygen dependence of energy metabolism in contracting and recovering rat skeletal muscle.
Am. J. Physiol.
248 (Heart Circ. Physiol. 17):
H40-H48,
1985.
19.
Jacobus, W. E.
Respiratory control and the integration of heart high-energy phosphate metabolism by mitochondrial creatine kinase.
Annu. Rev. Physiol.
47:
707-725,
1985[Medline].
20.
Jacobus, W. E.,
and
D. M. Diffley.
Creatine kinase of heart mitochondria.
J. Biol. Chem.
261:
16579-16583,
1986
21.
Katz, A.,
and
K. Sahlin.
Effect of decreased oxygen availability on NADH and lactate contents in human skeletal muscle during exercise.
Acta Physiol. Scand.
131:
119-127,
1987[Medline].
22.
Linnarsson, D. Dynamics of pulmonary gas exchange and heart
rate changes at start and end of exercise. Acta
Physiol. Scand. 415, Suppl.: 1-68, 1974.
23.
Linnarsson, D.,
J. Karlsson,
L. Fagraeus,
and
B. Saltin.
Muscle metabolites and oxygen deficit with exercise in hypoxia and hyperoxia.
J. Appl. Physiol.
36:
399-402,
1974
24.
MacDonald, M.,
P. K. Pedersen,
and
R. L. Hughson.
Acceleration of
O2 kinetics in heavy submaximal exercise by hyperoxia and prior high-intensity exercise.
J. Appl. Physiol.
83:
1318-1325,
1997
25.
Mahler, M.
First-order kinetics of muscle oxygen consumption, and an equivalent proportionality between
O2 and phosphorylcreatine level.
J. Gen. Physiol.
86:
135-165,
1985
26.
Marsh, G. D.,
D. H. Paterson,
J. J. Potwarka,
and
R. T. Thompson.
Transient changes in muscle high-intensity phosphates during moderate exercise.
J. Appl. Physiol.
75:
648-656,
1993
27.
McCann, D. J.,
P. A. Mole,
and
J. R. Caton.
Phosphocreatine kinetics in humans during exercise and recovery.
Med. Sci. Sports Exerc.
27:
378-387,
1995[Medline].
28.
McCreary, C. R.,
P. D. Chilibeck,
G. D. Marsh,
D. H. Paterson,
D. A. Cunningham,
and
R. T. Thompson.
Kinetics of pulmonary oxygen uptake and muscle phosphates during moderate-intensity calf exercise.
J. Appl. Physiol.
81:
1331-1338,
1996
29.
Meyer, R. A.
A linear model of muscle respiration explains monoexponential phosphocreatine changes.
Am. J. Physiol.
254 (Cell Physiol. 23):
C548-C553,
1988
30.
Richardson, R. S.,
D. R. Knight,
D. C. Poole,
S. S. Kurdak,
M. C. Hogan,
B. Grassi,
and
P. D. Wagner.
Determinants of maximal exercise
O2 during single leg knee-extensor exercise in humans.
Am. J. Physiol.
268 (Heart Circ. Physiol. 37):
H1453-H1461,
1995
31.
Richardson, R. S.,
E. A. Noyszewski,
K. F. Kendrick,
J. S. Leigh,
and
P. D. Wagner.
Myoglobin O2 destauration during exercise.
J. Clin. Invest.
96:
1916-1926,
1995.
32.
Richardson, R. S.,
E. A. Noyszewski,
J. S. Leigh,
and
P. D. Wagner.
Myoglobin PO2 as a determinant of maximal mitochondrial O2 consumption (Abstract).
Med. Sci. Sports Exerc.
29:
S272,
1997.
33.
Saks, V. A.,
L. V. Rosenshtraukh,
V. N. Smirnov,
and
E. I. Chazov.
Role of creatine phosphokinase in cellular function and metabolism.
Can. J. Physiol. Pharmacol.
56:
691-706,
1978[Medline].
34.
Taylor, D. J.,
P. J. Bore,
P. Styles,
D. G. Gadian,
and
G. K. Radda.
Bioenergetics of intact human muscle. A 31P nuclear magnetic resonance study.
Mol. Biol. Med.
1:
77-94,
1983[Medline].
35.
Wilson, D. F.,
and
M. Erecinska.
Effect of oxygen concentration on cellular metabolism.
Chest
88:
229S-232S,
1985
36.
Wilson, D. F.,
M. Erecinska,
C. Drown,
and
I. A. Silver.
Effect of oxygen tension on cellular energetics.
Am. J. Physiol.
233 (Cell Physiol. 2):
C135-C140,
1977
37.
Wilson, D. F.,
M. Erecinska,
C. Drown,
and
I. A. Silver.
The oxygen dependence of cellular energy metabolism.
Arch. Biochem. Biophys.
195:
485-493,
1979[Medline].
38.
Wittenberg, B. A.,
and
J. B. Wittenberg.
Transport of oxygen in muscle.
Annu. Rev. Physiol.
51:
857-878,
1989[Medline].
39.
Zimmer, S. D.,
K. Ugurbil,
S. P. Michurski,
P. Mohanakrishnan,
V. K. Ulstad,
J. E. Foker,
and
A. H. L. From.
Alterations in oxidative function and respiratory regulation in the post-ischemic myocardium.
J. Biol. Chem.
264:
12402-12411,
1989
This article has been cited by other articles:
![]() |
H. J. Green, M. E. Burnett, I. C. Smith, S. M. Tupling, and D. A. Ranney Failure of hypoxia to exaggerate the metabolic stress in working muscle following short-term training Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2009; 297(3): R593 - R604. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. J. Gurd, S. J. Peters, G. J. F. Heigenhauser, P. J. LeBlanc, T. J. Doherty, D. H. Paterson, and J. M. Kowalchuk Prior heavy exercise elevates pyruvate dehydrogenase activity and muscle oxygenation and speeds O2 uptake kinetics during moderate exercise in older adults Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2009; 297(3): R877 - R884. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Walsh, C. M. Stary, R. A. Howlett, K. M. Kelley, and M. C. Hogan Glycolytic activation at the onset of contractions in isolated Xenopus laevis single myofibres Exp Physiol, September 1, 2008; 93(9): 1076 - 1084. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Amann and J. A. L. Calbet Convective oxygen transport and fatigue J Appl Physiol, March 1, 2008; 104(3): 861 - 870. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. J. Haseler, A. Lin, J. Hoff, and R. S. Richardson Oxygen availability and PCr recovery rate in untrained human calf muscle: evidence of metabolic limitation in normoxia Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2007; 293(5): R2046 - R2051. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Amann, D. F. Pegelow, A. J. Jacques, and J. A. Dempsey Inspiratory muscle work in acute hypoxia influences locomotor muscle fatigue and exercise performance of healthy humans Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2007; 293(5): R2036 - R2045. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Amann, L. M. Romer, A. W. Subudhi, D. F. Pegelow, and J. A. Dempsey Severity of arterial hypoxaemia affects the relative contributions of peripheral muscle fatigue to exercise performance in healthy humans J. Physiol., May 15, 2007; 581(1): 389 - 403. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Katayama, M. Amann, D. F. Pegelow, A. J. Jacques, and J. A. Dempsey Effect of arterial oxygenation on quadriceps fatigability during isolated muscle exercise Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2007; 292(3): R1279 - R1286. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. J. Gurd, S. J. Peters, G. J. F. Heigenhauser, P. J. LeBlanc, T. J. Doherty, D. H. Paterson, and J. M. Kowalchuk Prior heavy exercise elevates pyruvate dehydrogenase activity and speeds O2 uptake kinetics during subsequent moderate-intensity exercise in healthy young adults J. Physiol., December 15, 2006; 577(3): 985 - 996. [Abstract] [Full Text] [PDF] |
||||
![]() |
J P Weir, T W Beck, J T Cramer, T J Housh, T D Noakes, A St Clair Gibson, and E V Lambert Is fatigue all in your head? A critical review of the central governor model * Commentary. Br. J. Sports Med., July 1, 2006; 40(7): 573 - 586. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Stellingwerff, P. J. LeBlanc, M. G. Hollidge, G. J. F. Heigenhauser, and L. L. Spriet Hyperoxia decreases muscle glycogenolysis, lactate production, and lactate efflux during steady-state exercise Am J Physiol Endocrinol Metab, June 1, 2006; 290(6): E1180 - E1190. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. J. Behnke, D. J. Padilla, L. F. Ferreira, M. D. Delp, T. I. Musch, and D. C. Poole Effects of arterial hypotension on microvascular oxygen exchange in contracting skeletal muscle J Appl Physiol, March 1, 2006; 100(3): 1019 - 1026. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. S. Richardson, S. Duteil, C. Wary, D. W. Wray, J. Hoff, and P. G. Carlier Human skeletal muscle intracellular oxygenation: the impact of ambient oxygen availability J. Physiol., March 1, 2006; 571(2): 415 - 424. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. McDonough, B. J Behnke, D. J Padilla, T. I Musch, and D. C Poole Control of microvascular oxygen pressures in rat muscles comprised of different fibre types J. Physiol., March 15, 2005; 563(3): 903 - 913. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A Timmons, D. Constantin-Teodosiu, S. M Poucher, and P. L Greenhaff Acetyl group availability influences phosphocreatine degradation even during intense muscle contraction J. Physiol., December 15, 2004; 561(3): 851 - 859. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. J. Haseler, A. P. Lin, and R. S. Richardson Skeletal muscle oxidative metabolism in sedentary humans: 31P-MRS assessment of O2 supply and demand limitations J Appl Physiol, September 1, 2004; 97(3): 1077 - 1081. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. J. Haseler, C. A. Kindig, R. S. Richardson, and M. C. Hogan The role of oxygen in determining phosphocreatine onset kinetics in exercising humans J. Physiol., August 1, 2004; 558(3): 985 - 992. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. McDonough, B. J. Behnke, T. I. Musch, and D. C. Poole Effects of chronic heart failure in rats on the recovery of microvascular PO2 after contractions in muscles of opposing fibre type Exp Physiol, July 1, 2004; 89(4): 473 - 485. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. S. DeLorey, C. N. Shaw, J. K. Shoemaker, J. M. Kowalchuk, and D. H. Paterson The effect of hypoxia on pulmonary O2 uptake, leg blood flow and muscle deoxygenation during single-leg knee-extension exercise Exp Physiol, May 1, 2004; 89(3): 293 - 302. [Abstract] [Full Text] [PDF] |
||||
![]() |
B.J Behnke, M.D Delp, P McDonough, S.A Spier, D.C Poole, and T.I Musch Effects of chronic heart failure on microvascular oxygen exchange dynamics in muscles of contrasting fiber type Cardiovasc Res, February 1, 2004; 61(2): 325 - 332. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Marcinek, W. A. Ciesielski, K. E. Conley, and K. A. Schenkman Oxygen regulation and limitation to cellular respiration in mouse skeletal muscle in vivo Am J Physiol Heart Circ Physiol, November 1, 2003; 285(5): H1900 - H1908. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Olive, J. M. Slade, G. A. Dudley, and K. K. McCully Blood flow and muscle fatigue in SCI individuals during electrical stimulation J Appl Physiol, February 1, 2003; 94(2): 701 - 708. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. S. Richardson, S. C. Newcomer, and E. A. Noyszewski Skeletal muscle intracellular PO2 assessed by myoglobin desaturation: response to graded exercise J Appl Physiol, December 1, 2001; 91(6): 2679 - 2685. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Perrey, M. E. Tschakovsky, and R. L. Hughson Muscle chemoreflex elevates muscle blood flow and O2 uptake at exercise onset in nonischemic human forearm J Appl Physiol, November 1, 2001; 91(5): 2010 - 2016. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Howlett and M. C. Hogan Intracellular PO2 decreases with increasing stimulation frequency in contracting single Xenopus muscle fibers J Appl Physiol, August 1, 2001; 91(2): 632 - 636. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Burnley, A. M. Jones, H. Carter, and J. H. Doust Effects of prior heavy exercise on phase II pulmonary oxygen uptake kinetics during heavy exercise J Appl Physiol, October 1, 2000; 89(4): 1387 - 1396. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Stary and M. C. Hogan Impairment of Ca2+ release in single Xenopus muscle fibers fatigued at varied extracellular PO2 J Appl Physiol, May 1, 2000; 88(5): 1743 - 1748. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. Parolin, L. L. Spriet, E. Hultman, M. G. Hollidge-Horvat, N. L. Jones, and G. J. F. Heigenhauser Regulation of glycogen phosphorylase and PDH during exercise in human skeletal muscle during hypoxia Am J Physiol Endocrinol Metab, March 1, 2000; 278(3): E522 - E534. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Howlett, G. J. F. Heigenhauser, and L. L. Spriet Skeletal muscle metabolism during high-intensity sprint exercise is unaffected by dichloroacetate or acetate infusion J Appl Physiol, November 1, 1999; 87(5): 1747 - 1751. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Tschakovsky and R. L. Hughson Ischemic muscle chemoreflex response elevates blood flow in nonischemic exercising human forearm muscle Am J Physiol Heart Circ Physiol, August 1, 1999; 277(2): H635 - H642. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. S. Richardson, J. S. Leigh, P. D. Wagner, and E. A. Noyszewski Cellular PO2 as a determinant of maximal mitochondrial O2 consumption in trained human skeletal muscle J Appl Physiol, July 1, 1999; 87(1): 325 - 331. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Stary and M. C. Hogan Effect of varied extracellular PO2 on muscle performance in Xenopus single skeletal muscle fibers J Appl Physiol, June 1, 1999; 86(6): 1812 - 1816. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. J. Haseler, M. C. Hogan, and R. S. Richardson Skeletal muscle phosphocreatine recovery in exercise-trained humans is dependent on O2 availability J Appl Physiol, June 1, 1999; 86(6): 2013 - 2018. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Tschakovsky and R. L. Hughson Interaction of factors determining oxygen uptake at the onset of exercise J Appl Physiol, April 1, 1999; 86(4): 1101 - 1113. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Hogan, R. S. Richardson, and L. J. Haseler Human muscle performance and PCr hydrolysis with varied inspired oxygen fractions: a 31P-MRS study J Appl Physiol, April 1, 1999; 86(4): 1367 - 1373. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Hogan Phosphorescence quenching method for measurement of intracellular PO2 in isolated skeletal muscle fibers J Appl Physiol, February 1, 1999; 86(2): 720 - 724. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |